The management of osteoporosis in children

LM Ward, VN Konji, J Ma - Osteoporosis International, 2016 - Springer
This article reviews the manifestations and risk factors associated with osteoporosis in
childhood, the definition of osteoporosis and recommendations for monitoring and …

Bone health in children with rheumatic disorders: focus on molecular mechanisms, diagnosis, and management

F Di Marcello, G Di Donato, DM d'Angelo… - International Journal of …, 2022 - mdpi.com
Bone is an extremely dynamic and adaptive tissue, whose metabolism and homeostasis is
influenced by many different hormonal, mechanical, nutritional, immunological and …

Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study

C Rodd, B Lang, T Ramsay, N Alos… - Arthritis care & …, 2012 - Wiley Online Library
Objective To determine the frequency of incident vertebral fractures (IVF) 12 months after
glucocorticoid (GC) initiation in children with rheumatic diseases and to identify children at …

Incident vertebral fractures and risk factors in the first three years following glucocorticoid initiation among pediatric patients with rheumatic disorders

CMA LeBlanc, J Ma, M Taljaard, J Roth… - Journal of Bone and …, 2015 - academic.oup.com
Vertebral fractures are an important yet underrecognized manifestation of osteoporosis in
children with chronic, glucocorticoid‐treated illnesses. Our goal was to determine the …

Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders

AM Huber, I Gaboury, DA Cabral, B Lang… - Arthritis care & …, 2010 - Wiley Online Library
Objective Vertebral fractures are an under‐recognized problem in children with inflammatory
disorders. We studied spine health among 134 children (87 girls) with rheumatic conditions …

A systematic review and meta-analysis of glucocorticoid-induced osteoporosis in children

KE Hansen, B Kleker, N Safdar, CM Bartels - Seminars in arthritis and …, 2014 - Elsevier
Objective To summarize the published effects of systemic glucocorticoid therapy on bone
mineral density (BMD) and fractures in children. Methods We performed a systematic review …

Vertebral morphology in aromatase inhibitor–treated males with idiopathic short stature or constitutional delay of puberty

M Hero, S Toiviainen‐Salo, S Wickman… - Journal of Bone and …, 2010 - academic.oup.com
Aromatase inhibitors (AIs), blockers of estrogen biosynthesis, delay bone maturation and
therefore are used increasingly to promote growth in children and adolescents with growth …

Optimizing bone health in Duchenne muscular dystrophy

JL Buckner, SA Bowden… - International Journal of …, 2015 - Wiley Online Library
Duchenne muscular dystrophy (DMD) is an X‐linked recessive disorder characterized by
progressive muscle weakness, with eventual loss of ambulation and premature death. The …

Glucocorticoid-associated osteoporosis in chronic inflammatory diseases: epidemiology, mechanisms, diagnosis, and treatment

E Von Scheven, KJ Corbin, S Stefano… - Current osteoporosis …, 2014 - Springer
Children with chronic illnesses such as Juvenile Idiopathic Arthritis and Crohn's disease,
particularly when taking glucocorticoids, are at significant risk for bone fragility. Furthermore …

Causes, mechanisms and management of paediatric osteoporosis

O Mäkitie - Nature reviews rheumatology, 2013 - nature.com
Osteoporosis, a skeletal disorder characterized by compromised bone strength and an
increased risk of fractures, is an important paediatric disorder that involves almost all …